Hardware Podcasts

#394: Class III PMAs in MedTech: Advantages, Misconceptions, and Competitive Strategies with Dr. Mike Drues

Global Medical Device Podcast · 6 Dec 2024 · 51m · Episode 394

What this episode covers

Regulatory expert Dr. Mike Drues joins host Etienne Nichols to demystify the Pre-Market Approval (PMA) pathway for Class III medical devices, arguing that its high regulatory burden is often justified by the complexity and risk of the devices involved. Drues explains that PMAs are not the only option for Class III devices, highlighting alternatives like the Humanitarian Device Exemption (HDE) and the Product Development Protocol (PDP), and details the strategic advantages of using PMAs to create competitive barriers against rivals. He also clarifies misconceptions about clinical data requirements, the use of predicates in engineering terms, and the 'six-year rule' which allows leveraging data from older approved devices to reduce regulatory burden.

Most relevant to

large enterprises

Topics

Mentioned

Companies
Greenlight Guru
Also
FDA, CMS

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 37m

    118 - What are Drug/Device Master Files and When to Use for Combination Product Submissions? with Doug Mead

    Doug Mead, founder of CP Pathways, explains the regulatory differences between Drug Master Files (DMFs) and Device Master Files (MAFs) for combination products. He details the five types of DMFs and contrasts them with the less formal MAFs, noting that CDRH and CDER often lack cross-access to each other's files. Mead argues that for finished devices or platforms, it is often more efficient to include device content directly in Module 3.2.R of an NDA or BLA rather than maintaining a separate MAF. He highlights challenges such as supplier reluctance to grant Letters of Authorization and the redundancy of updating both a master file and a supplement.

    Certification & complianceMedical & health devices
    8 chapters

  • Let's Combinate · 44m

    058 - PMSR Globally, Different Clinical Roles and Risk Management with Khaudeja Bano

    Dr. Khaudeja Bano, Vice President of Combination Product Quality at Amgen, discusses the global regulatory landscape for post-market surveillance reporting (PMSR) and the distinct clinical roles within pharmaceutical and medical device companies. She explains how risk management must be integrated into a closed-loop lifecycle, contrasting the condensed timelines of device development with the extended phases of pharmaceutical trials. Bano details the organizational structures of medical affairs, pharmacovigilance, and clinical teams, highlighting the significant variability in global reporting requirements and the ongoing challenges in harmonization across different geographies.

    Quality & yieldCertification & compliance
    7 chapters

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

    Crowdfunding & preordersValidation & product-market fit
    8 chapters

  • Let's Combinate · 47m

    068 - Benefit/Risk Ratios, PRRC, and Mythical Medical with David Rutledge

    David Rutledge, CEO of Global Strategic Solutions and author of 'Mythical Medical', discusses the critical importance of demonstrating product benefit in medical device development, arguing that the industry has historically focused too heavily on risk. He details the role of the Person Responsible for Regulatory Compliance (PRRC) under EU MDR, emphasizing the need for cross-functional teams to define and validate benefits through diverse data sources. Rutledge also shares insights from his book, using narrative characters to illustrate common regulatory pitfalls, audit preparation strategies, and the emotional weight of ensuring patient safety in combination products.

    Medical & health devicesCertification & compliance
    13 chapters

  • Being an Engineer · 51m

    S6E19 Stuart Grant | MedTech Innovation

    Dr. Stuart Grant, founder of Archetype MedTech, discusses his 25-year career at Johnson & Johnson and DePuy Synthes before launching his consultancy to help startups navigate medical device development. He details the challenges of securing funding, managing regulatory differences between the EU's MDR and the US FDA, and the strategic importance of narrow clinical indications. Grant also explores future trends in surgical robotics and AI, emphasizing the need for modular platforms and the value of accumulated engineering knowledge.

    Starting a product companyMedical & health devices
    11 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.